Past year
All results
- All results
- Verbatim
Apr 26, 2024 · We speculate how allogeneic stem cell transplantation could be modified to maximise its therapeutic effect on refractory acute myeloid leukaemia.
Nov 20, 2023 · ... Patients with Acute Myeloid Leukemia: A Study on Behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation
Missing: Group | Show results with:Group
Jan 30, 2024 · Patients age ≥70 years with acute myelogenous leukemia have a 2-year survival after hematopoietic stem cell transplantation of 38%. •. Patients with a Karnofsky ...
Missing: syndromes | Show results with:syndromes
May 30, 2024 · Prognostic impact of donor source on allogeneic hematopoietic stem cell transplantation outcomes in adults with chronic myelomonocytic leukemia.
May 2, 2024 · Second allogeneic stem cell transplantation (alloSCT2) is among the most effective treatments for acute myeloid leukemia (AML) relapse after first alloSCT ...
Mar 6, 2024 · Final Decision: We are expanding Medicare coverage for allogeneic hematopoietic stem cell transplant using bone marrow, peripheral blood or umbilical cord blood ...
Mar 3, 2024 · The aim of our study was to investigate the key characteristics of Haplo family donors that could have an impact on transplant outcomes in patients with acute ...
Dec 7, 2023 · We propose to expand Medicare coverage for allogeneic hematopoietic stem cell transplant using only bone marrow or peripheral blood stem cell products.
Missing: Leukaemia | Show results with:Leukaemia
Dec 28, 2023 · The only potential cure is allogeneic stem cell transplantation, and albeit the fraction of patients with MDS who undergo transplant increase over time because ...
Dec 28, 2023 · The only potential cure is allogeneic stem cell transplantation, and albeit the fraction of patients with MDS who undergo transplant increase over time because ...